7 studies found for:    "Therapeutics, Inc." [Exact]
Show Display Options
Rank Status Study
1 Recruiting A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Condition: Plaque Psoriasis
Interventions: Drug: 000-0551 Lotion;   Drug: Vehicle Lotion
2 Completed Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression
Condition: Plaque Psoriasis
Intervention: Drug: 122-0551
3 Completed Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Halobetasol Proprionate Lotion 0.05%;   Drug: Halobetasol Proprionate Cream 0.05%
4 Completed A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: 122-0551;   Drug: Vehicle
5 Completed A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: Halobetasol Propionate Lotion 0.05%;   Drug: Placebo
6 Recruiting Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)
Condition: Lymphoma, T-Cell, Cutaneous
Interventions: Drug: SHP-141;   Drug: placebo fo SHP-141
7 Completed A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis
Condition: Psoriasis Vulgaris
Intervention: Drug: PTH (1-34) Gel / Placebo Gel

Indicates status has not been verified in more than two years